GALWAY, Ireland--(BUSINESS WIRE)--Oct 22, 2020--
Aerogen, the global leader in aerosol drug delivery, today announced details of a broad collaborative effort to support pharmaceutical companies from around the world as they work to develop COVID-19 vaccines and treatments. To date, more than ten million patients
"Aerogen is a highly regarded global company known for providing safe and effective aerosol drug delivery,"
Related News
Global Aerosol Delivery Devices Market (2020 to 2027) - by Product, Application and Distribution Channel
DUBLIN, Oct. 22, 2020 /PRNewswire/ -- The "Aerosol Delivery Devices Market by Product, Application and Distribution Channel: Global Opportunity Analysis and Industry...
PR Newswire 2020-10-22Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled ...
BOSTON and DURHAM, N.C., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to...
Tyler Morning Telegraph
2020-10-20
SEC Filing (8-K) - Current Report Filing
Exhibit 99.1 Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for...
Public Technologies 2020-10-19Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients
Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19...
Public Technologies 2020-10-19Coronavirus: which treatments work and which don’t?
PongMoji/Shutterstock Donald Trump’s brief stay in hospital in early October raised awareness – once again – of the variety of treatments being investigated for COVID-19....
The Conversation 2020-10-22Beyond Air® Approved to Initiate Clinical Study at 150 ppm Nitric Oxide with LungFit™ for the Treatment of Acute Viral Pneumonia Including COVID-19
Beyond Air® Approved to Initiate Clinical Study at 150 ppm Nitric Oxide with LungFit™ for the Treatment of Acute Viral Pneumonia Including COVID-19 October 21, 2020 7:00am...
Public Technologies 2020-10-21Beyond Air® Presents Pilot Bronchiolitis Data at the CHEST Annual Meeting 2020
Beyond Air® Presents Pilot Bronchiolitis Data at the CHEST Annual Meeting 2020 October 19, 2020 7:00am EDT 150ppm nitric oxide was statistically significant compared to...
Public Technologies 2020-10-19